How the endocytic network mediates specificity of cell signaling
内吞网络如何介导细胞信号传导的特异性
基本信息
- 批准号:10623603
- 负责人:
- 金额:$ 51.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAutoimmune DiseasesBiological ProcessCOVID-19Cancer VaccinesCardiovascular DiseasesCell NucleusCell membraneCell physiologyCellsChemicalsCommunicable DiseasesComputer ModelsCuesDevelopmentDiseaseEndocytosisEndosomesFeedbackFoundationsFunctional disorderGoalsImmunologic AdjuvantsInflammatory ResponseKnowledgeLengthMalignant NeoplasmsMediatingMissionModelingOrganellesPathogenesisPlayPreventionPublic HealthReceptor Cross-TalkReportingResearchRoleSignal TransductionSortingSpecificityStimulusUnited States National Institutes of Healthcancer therapycombinatorialdisease diagnosisendosome membraneexperimental studyextracellularhuman diseasenovelnovel strategiesnovel therapeutic interventionreceptorresponsespatiotemporal
项目摘要
Abstract: How the endocytic network mediates specificity of cell signaling
Receptor crosstalk – the cooperation between two or more receptors to modulate cell responses – is a key
signaling mechanism. It enables cells to generate a large combinatorial repertoire of specific signaling with a
limited variety of receptors. Receptor crosstalk plays an essential role in cell physiology. Consequently,
dysfunctions in receptor crosstalk are associated with many human diseases, such as infectious diseases
(including COVID-19), cancer, and cardiovascular diseases. To understand the physical mechanisms by which
signals from different receptors are integrated in crosstalk, studies have exclusively focused on receptor
interactions at the plasma membrane. In contrast, how the crosstalk signals are transduced with high fidelity
from the plasma membrane to the nucleus is poorly understood and scarcely explored.
The overall goal of this research is to establish the functional role of the endocytic network in transducing and
regulating receptor crosstalk. Under the prior ESI-R35 support, our group has made pioneering discoveries
in support of the central hypothesis that the endocytic network is where extracellular chemical and
physical stimuli intertwine to regulate receptor crosstalk. Specifically, we reported a new model in which
receptors can crosstalk by forming overlapping interfaces between discrete signaling clusters, challenging the
prevailing view that receptors oligomerize to crosstalk. Importantly, such spatially organized interaction between
receptors at endosomes and plasma membranes is modulated by extracellular physical cues, and directly
regulates cell inflammatory responses. These prior discoveries and the plethora of new approaches we
developed for studying endosome functions laid a critical and unique foundation for us to address the
knowledge gap: how does the endocytic network mediate receptor crosstalk? We will address how the
endocytic network orchestrates chemical cues from receptor crosstalk (Direction 1), and transduces
extracellular physical cues to refine the specificity of crosstalk signaling (Direction 2). To address the first
direction, we will define the physical mechanisms by which endocytic sorting, collective endosome-organelle
interactions, and endosome-specific activation modulate crosstalk signaling originated from the plasma
membrane. To address the second direction, we will integrate experiments with computational modeling to
determine the feedback loop between the endocytic network and cell-matrix interactions that regulate receptor
crosstalk. This project will establish a mechanistic and predictive understanding of how the endocytic network
mediates the spatiotemporal specificity of receptor crosstalk and cell signaling in general; a topic that is poorly
understood. It will also lower the technical barrier that has impeded research on this topic, by establishing novel
quantitative toolsets for dissecting the dynamics and function of the endocytic network on multiple length scales.
Ultimately, a better understanding of endosome functions in receptor crosstalk will facilitate the development of
new therapeutic strategies for diseases, such as immune adjuvants for cancer therapies and vaccines.
翻译后摘要:内吞网络如何介导细胞信号的特异性
受体串扰-两个或多个受体之间的合作,以调节细胞反应-是一个关键
信号机制它使细胞能够产生大量的特异性信号组合,
受体种类有限。受体串扰在细胞生理学中起着重要作用。因此,委员会认为,
受体串扰的功能障碍与许多人类疾病有关,例如传染病
(包括COVID-19)、癌症及心血管疾病。为了理解
来自不同受体的信号被整合在串扰中,研究仅集中在受体上。
在质膜上的相互作用。相反,如何以高保真度转换串扰信号
从质膜到细胞核的过程知之甚少,几乎没有探索。
本研究的总体目标是建立内吞网络在转导和调节细胞内信号转导中的功能作用,
调节受体串扰。在先前的ESI-R35支持下,我们的团队取得了开创性的发现,
支持核心假设,即内吞网络是细胞外化学物质和
物理刺激干扰调节受体串扰。具体来说,我们报告了一种新模型,
受体可以通过在离散的信号簇之间形成重叠的界面而串扰,挑战了
普遍认为受体寡聚化形成串扰。重要的是,这种空间上有组织的相互作用,
内体和质膜上的受体受细胞外物理信号的调节,
调节细胞炎症反应。这些先前的发现和过多的新方法,
为研究核内体功能而开发的一个关键和独特的基础,为我们解决核内体功能奠定了重要的基础。
知识缺口:内吞网络如何介导受体串扰?我们将讨论如何
内吞网络协调来自受体串扰的化学线索(方向1),并转导
细胞外物理线索,以细化串扰信号传导的特异性(方向2)。为了解决第一个
方向,我们将定义的物理机制,内吞分选,集体内体细胞器
相互作用和内体特异性激活调节源自血浆的串扰信号传导
膜的为了解决第二个方向,我们将结合实验与计算建模,
确定内吞网络和调节受体的细胞-基质相互作用之间的反馈回路
串话。这个项目将建立一个机制和预测性的理解如何内吞网络
介导受体串扰和细胞信号传导的时空特异性;这是一个很难理解的话题。
明白它还将通过建立新的技术平台,降低阻碍这一主题研究的技术壁垒。
用于在多个长度尺度上解剖内吞网络的动力学和功能的定量工具集。
最终,更好地理解受体串扰中的内体功能将促进
新的疾病治疗策略,如癌症治疗和疫苗的免疫佐剂。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Macrophage activation on "phagocytic synapse" arrays: Spacing of nanoclustered ligands directs TLR1/2 signaling with an intrinsic limit.
- DOI:10.1126/sciadv.abc8482
- 发表时间:2020-12
- 期刊:
- 影响因子:13.6
- 作者:Li M;Wang H;Li W;Xu XG;Yu Y
- 通讯作者:Yu Y
Anisotropic presentation of ligands on cargos modulates degradative function of phagosomes
货物上配体的各向异性呈现调节吞噬体的降解功能
- DOI:10.1016/j.bpr.2021.100041
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Jiao, Mengchi;Li, Wenqian;Yu, Yanqi;Yu, Yan
- 通讯作者:Yu, Yan
Tracking Single Molecules in Biomembranes: Is Seeing Always Believing?
- DOI:10.1021/acsnano.9b07445
- 发表时间:2019-10-01
- 期刊:
- 影响因子:17.1
- 作者:Yu,Yanqi;Li,Miao;Yu,Yan
- 通讯作者:Yu,Yan
Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially regulates their synergistic and inhibitory receptor crosstalk.
- DOI:10.1038/s41598-021-92910-9
- 发表时间:2021-06-28
- 期刊:
- 影响因子:4.6
- 作者:Li W;Li M;Anthony SM;Yu Y
- 通讯作者:Yu Y
Nanoparticles for Interrogation of Cell Signaling.
- DOI:10.1146/annurev-anchem-092822-085852
- 发表时间:2023-06
- 期刊:
- 影响因子:0
- 作者:Seonik Lee;Mengchi Jiao;Zihan Zhang;Yan Yu
- 通讯作者:Seonik Lee;Mengchi Jiao;Zihan Zhang;Yan Yu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yan Yu其他文献
Yan Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yan Yu', 18)}}的其他基金
Targeting Lysine-specific Demethylase 1 to Enhance the Post-transplant Graft-versus-leukemia Effect
靶向赖氨酸特异性去甲基酶 1 增强移植后移植物抗白血病效应
- 批准号:
467033 - 财政年份:2021
- 资助金额:
$ 51.09万 - 项目类别:
Studentship Programs
Decoupling Receptor Clusters and Signaling Crosstalk in Phagosome Membranes
吞噬体膜中受体簇的解耦和信号串扰
- 批准号:
9387826 - 财政年份:2017
- 资助金额:
$ 51.09万 - 项目类别:
Unravelling Mechanisms of Endosomal Signaling with Designer Nanomaterials
用设计纳米材料揭示内体信号传导机制
- 批准号:
10172924 - 财政年份:2017
- 资助金额:
$ 51.09万 - 项目类别:
Unravelling Mechanisms of Endosomal Signaling with Designer Nanomaterials
用设计纳米材料揭示内体信号传导机制
- 批准号:
9382294 - 财政年份:2017
- 资助金额:
$ 51.09万 - 项目类别:
Sono-Contrast Induced Functional Imaging/Spectroscopy
声对比诱导功能成像/光谱
- 批准号:
7230953 - 财政年份:2004
- 资助金额:
$ 51.09万 - 项目类别:
Sono-Contrast Induced Functional Imaging/Spectroscopy
声对比诱导功能成像/光谱
- 批准号:
7341355 - 财政年份:2004
- 资助金额:
$ 51.09万 - 项目类别:
Sono-Contrast Induced Functional Imaging/Spectroscopy
声对比诱导功能成像/光谱
- 批准号:
7115008 - 财政年份:2004
- 资助金额:
$ 51.09万 - 项目类别:
Orthogonal ultrasound for cancer detection and therapy
用于癌症检测和治疗的正交超声
- 批准号:
6924608 - 财政年份:2004
- 资助金额:
$ 51.09万 - 项目类别:
Sono-Contrast Induced Functional Imaging/Spectroscopy
声对比诱导功能成像/光谱学
- 批准号:
7090151 - 财政年份:2004
- 资助金额:
$ 51.09万 - 项目类别:
Orthogonal ultrasound for cancer detection and therapy
用于癌症检测和治疗的正交超声
- 批准号:
7341339 - 财政年份:2004
- 资助金额:
$ 51.09万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 51.09万 - 项目类别: